Here, we demonstrate that a VCAM-1–targeted imaging approach has the potential to better detect brain tumor margins, using preclinical models of breast cancer brain metastasis and glioblastoma, than currently used clinical MRI methods. Here, VCAM1 is linked to glioblastoma.